Antibody Discovery Market Analysis and Insights: 2024, Progressive Growth Rate, Competitive Analysis with Top Players - Biocytogen, Charles River Laboratories, Creative Biolabs

Introduction -

The antibody discovery market is a rapidly evolving sector within biotechnology, focusing on the identification and development of antibodies for therapeutic, diagnostic, and research purposes. Antibodies, as critical components of the immune system, have become vital tools in treating a wide range of diseases, including cancers, autoimmune disorders, and infectious diseases. The market's growth is driven by advancements in technology, increasing prevalence of chronic diseases, and a rising focus on personalized medicine.

Market Size and Growth -

The Antibody Discovery Market is Valued USD 6.9 billion by 2024 and projected to reach USD 14.98 billion by 2032, growing at a CAGR of 9.0% During the Forecast period of 2024-2032. This growth is fueled by the increasing demand for novel antibody therapeutics and the adoption of advanced technologies such as high-throughput screening, next-generation sequencing, and artificial intelligence in antibody discovery.

Download the Sample: https://www.marketdigits.com/request/sample/3712

Important Features that are under Offering Antibody Discovery Market Highlights of the Reports:

⋆ Detailed Overview of this Market
⋆ Changes in industry market dynamics
⋆ Detailed market segmentation by type, application, etc.
⋆ The historical, current, and projected market size in terms of quantity and value
⋆ Recent industry trends and developments
⋆ Competition situation of this market
⋆ Key companies and product strategies
⋆ Potential niche segment/region showing promising growth.

The list of Key Players Profiled in the study includes:-

Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, Twist Bioscience and Others.

The detailed segments and sub-segment of the market are explained below:

By Source
• Humanized Antibody
• Human Antibody
• Chimeric Antibody
• Murine Antibody

By Type
• Monoclonal Antibodies (mAbs)
• Polyclonal Antibodies
• Recombinant Antibodies

By Technology
• Phage Display
• Hybridoma
• Transgenic Antibody Technology
• Single B Cell Technology
• Others

By End-user
• Pharmaceutical & Biotechnology industry
• Research laboratory
• Academic laboratory

Regions Covered in Market Report:

• North America (United States, Canada, and Mexico)
• Europe (Germany, France, UK, Russia, Italy)
• Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

To Directly Buy This Report @ https://www.marketdigits.com/checkout/3712?lic=s

The following are the study objectives for this report:

◘ SWOT Analysis focuses on worldwide main manufacturers to define, assess, and analyze market competition. By kind, application, and region, the market is defined, described, and forecasted.
◘ Examine the global and main regional market potential and advantage, opportunity and challenge, constraints and risks.
◘ Determine whether trends and factors are driving or limiting market growth.
◘ By identifying high-growth categories, stakeholders would be able to analyze market potential.
◘ Conduct a strategic study of each submarket's growth trends and market contribution.
◘ Expansions, agreements, new product launches, and acquisitions in the market are all examples of competitive developments.
◘ To create a strategic profile of the main players and analyze their growth plans in depth.

Key Segments -

• Therapeutic Antibodies: The largest segment, driven by the development of monoclonal antibodies (mAbs) for treating diseases such as cancer, rheumatoid arthritis, and multiple sclerosis.
• Diagnostic Antibodies: Used in diagnostic assays and tests, these antibodies are critical for detecting biomarkers associated with various diseases.
• Research Antibodies: Widely used in academic and pharmaceutical research to study protein functions and disease mechanisms.

Key Technologies -

• Hybridoma Technology: A traditional method for monoclonal antibody production involving the fusion of B cells with myeloma cells.
• Phage Display: A technique that uses bacteriophages to connect proteins with the genetic information that encodes them, enabling the identification of high-affinity antibodies.
• Single B Cell Technologies: Allow the isolation and cloning of antibodies from single B cells, providing a more natural representation of the antibody repertoire.
• Next-Generation Sequencing (NGS): Enhances the ability to decode the antibody repertoire at an unprecedented scale and speed.
• Artificial Intelligence (AI): AI and machine learning algorithms are increasingly used to predict antibody-antigen interactions and optimize antibody engineering.

Key Trends -

✦ Personalized Medicine: The shift towards personalized medicine is driving the development of tailored antibody therapies based on individual genetic profiles.

✦ Bispecific Antibodies: These antibodies can simultaneously bind two different antigens, offering enhanced therapeutic potential, especially in oncology.

✦ Antibody-Drug Conjugates (ADCs): Combining antibodies with cytotoxic drugs to target and kill cancer cells specifically, minimizing damage to healthy cells.

✦ Humanization and Deimmunization: Techniques to reduce the immunogenicity of therapeutic antibodies, making them safer for human use.

✦ Emergence of Biosimilars: As patents for blockbuster mAbs expire, biosimilars are entering the market, providing more cost-effective therapeutic options.

We Offer Customized Report, Click @ https://www.marketdigits.com/request/customization/3712

Recent Industry News -

✦ Partnerships and Collaborations: Major pharmaceutical companies are increasingly entering partnerships with biotech firms and academic institutions to accelerate antibody discovery. For instance, collaborations between industry leaders like Roche and Regeneron with smaller biotech firms have led to significant advancements in antibody therapeutics.

✦ Technological Innovations: Recent advancements include the development of AI-powered platforms for predicting antibody-antigen interactions and optimizing antibody sequences. Companies like AbCellera and Berkeley Lights are at the forefront of integrating AI with antibody discovery.

✦ Regulatory Approvals: The FDA and EMA have recently approved several novel antibody-based therapies, highlighting the market's growth and the increasing acceptance of antibodies as a standard treatment modality.

✦ COVID-19 Impact: The pandemic has underscored the importance of rapid antibody discovery, leading to accelerated development timelines and emergency use authorizations for antibody-based therapies targeting SARS-CoV-2.

Table of Content (TOC):

Chapter 1: Introduction and Overview

Chapter 2: Industry Cost Structure and Economic Impact

Chapter 3: Rising Trends and New Technologies with Major Key Players

Chapter 4: Global Antibody Discovery Market Analysis, Trends, Growth Factor

Chapter 5: Antibody Discovery Market Application and Business with Potential Analysis

Chapter 6: Global Market Segment, Type, Application

Chapter 7: Global Antibody Discovery Market Analysis (by Application, Type, End User)

Chapter 8: Major Key Vendors Analysis of Antibody Discovery Market

Chapter 9: Development Trend of Analysis

Chapter 10: Conclusion

https://www.globenewswire.com/en/news-release/2023/12/05/2791157/0/en/Antibody-Discovery-Market-projected-to-reach-USD-13-7-Billion-by-2030-growing-at-a-CAGR-of-9-0-during-the-forecast-period-of-2023-2030-a-comprehensive-study-by-MarketDigits.html

Contact Us:

MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com

About MarketDigits:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

This release was published on openPR.